Qube Research & Technologies (QRT)’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIB
CIA
KFS
PWM
JF
CIC
TFA
ATPW
Qube Research & Technologies (QRT)'s BIB Position: Q2 2026 in Review
Qube Research & Technologies (QRT) reduced its ProShares Ultra NASDAQ Biotechnology (BIB) stake by 2% in Q2 2026, selling an estimated $84 and leaving 49 shares worth $4.94K. The position accounts for ﹤0.01% of the portfolio, ranked #3322.
Qube Research & Technologies (QRT) first reported a position in BIB in Q4 2021 and has held it in 18 quarters since. The position peaked at $111K in Q4 2021. 20 funds tracked by Wall St. Rank hold BIB as of Q2 2026.
- Qube Research & Technologies (QRT) held 49 shares of ProShares Ultra NASDAQ Biotechnology worth $4.94K as of Q2 2026.
- Qube Research & Technologies (QRT) sold 1 ProShares Ultra NASDAQ Biotechnology share in Q2 2026, an estimated $84.
- ProShares Ultra NASDAQ Biotechnology made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #3322 holding.
- Qube Research & Technologies (QRT) first reported a position in ProShares Ultra NASDAQ Biotechnology in Q4 2021 and has held it in 18 quarters since.
- Qube Research & Technologies (QRT)'s ProShares Ultra NASDAQ Biotechnology position peaked at $111K in Q4 2021.
- 20 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q2 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.